+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07519902

Multicenter Randomized Study Comparing Cenegermin Eye Drops to Placebo for Healing Persistent Corneal Epithelial Defects

Led by Dompé Farmaceutici S.p.A · Updated on 2026-10-07

150

Participants Needed

77

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the safety and effectiveness of cenegermin eye drops to heal persistent corneal epithelial defects PCED, a condition where the cornea does not properly heal. This phase 3 clinical trial compares cenegermin with a placebo vehicle to see how well it induces complete healing after 4 weeks of treatment. The study is conducted across multiple centers with participants randomly assigned to groups, and both participants and researchers do not know who receives which treatment. Participants will receive either cenegermin or a placebo eye drop applied topically to the affected eye. The study includes three periods an initial 8-week treatment phase, followed by an 8-week extension treatment phase for continued evaluation, and finally a 24-week follow-up phase to monitor long-term outcomes. Participants are randomly assigned to one of the two groups, and the treatment is administered throughout these periods. During the study, participants will be regularly assessed to monitor corneal healing and safety. Measurements include the proportion of participants achieving complete healing at 4 and 8 weeks, changes in the size of the corneal defect, and monitoring of any adverse events up to week 40. Study visits and evaluations will track progress and safety over the total study duration, ensuring careful follow-up of all participants.

CONDITIONS

Brief Title

An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

Research Team

D

Dompé farmaceutici S.p.A. Via Santa Lucia, 6, 20122 Milan (MI)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here